A design strategy that minimizes the susceptibility of HIV-1 protease inhibitors to mutations causing drug resistance
Congress:
16th Meeting of Groups Studying the Structures of AIDS-related Systems and their Application to Targeted Drug Design (NIH)
Participation type:
Comunicación oral
Other authors:
A. Velazquez-Campoy, I. Luque, S. Muzammil, H. Ohtaka, S. Vega, P. Ross, E. Freire
Year:
2002
Location:
Bethesda
Publication:
A. Velazquez-Campoy, I. Luque, S. Muzammil, H. Ohtaka, S. Vega, P. Ross, E. Freire. A design strategy that minimizes the susceptibility of HIV-1 protease inhibitors to mutations causing drug resistance. En: 16th Meeting of Groups Studying the Structures of AIDS-related Systems and their Application to Targeted Drug Design (NIH). Bethesda, 2002